Nimotuzumab in pediatric glioma
Author:
Affiliation:
1. The Hospital for Sick Children, Division for Haematology/Oncology, 555 University Ave, Toronto, M5G 1X8 Canada
2. The Hospital for Sick Children, Division for Haematology/Oncology, 555 University Ave, Toronto, M5G 1X8 Canada.
Abstract
Publisher
Future Medicine Ltd
Subject
Cancer Research,Oncology,General Medicine
Link
https://www.futuremedicine.com/doi/pdf/10.2217/fon.09.119
Reference85 articles.
1. Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification
2. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
3. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma
4. High-grade Astrocytomas in Children: Radiologically Complete Resection Is Associated with an Excellent Long-term Prognosis
5. The influence of central review on outcome associations in childhood malignant gliomas: Results from the CCG-945 experience
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma;International Journal of Molecular Sciences;2023-07-05
2. Nimotuzumab therapy in the treatment of pediatric central nervous system tumors: single-center experience;Naunyn-Schmiedeberg's Archives of Pharmacology;2021-06-21
3. Receptor Tyrosine Kinases: Principles and Functions in Glioma Invasion;Advances in Experimental Medicine and Biology;2020
4. Long term survival in diffuse infiltrative brainstem gliomas in children and adolescents treated with radiatherapy and Nimotuzumab;International Journal of Radiology & Radiation Therapy;2018-08-28
5. Long term survival in diffuse infiltrative brainstem gliomas in children and adolescents treated with radiotherapy and Nimotuzumab;International Journal of Radiology & Radiation Therapy;2018-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3